Related Experiment Video
Updated: Jun 23, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Topical treatments for psoriasis in 2009]
Anne-Marie Thielen1, Emmanuel Laffitte
1Clinique policlinique de dermatologie, HUG, 1211 Genève 14. anne-marie@thielen.net
Revue Medicale Suisse
|May 15, 2009
Summary
Psoriasis is a chronic inflammatory skin condition causing significant physical and psychological distress. This review covers the primary topical treatment options for managing mild to moderate psoriasis effectively.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Context:
- Psoriasis is a prevalent chronic inflammatory dermatosis.
- It significantly impacts patients' physical and psychological well-being.
- Topical therapies are foundational for mild to moderate disease management.
Purpose:
- To provide a comprehensive overview of current topical treatment options for psoriasis.
- To guide clinicians in selecting appropriate therapies for patients with mild to moderate psoriasis.
Summary:
- This review synthesizes information on various topical agents used in psoriasis treatment.
- It details the mechanisms of action, efficacy, and safety profiles of key therapeutic classes.
- Key considerations for optimizing topical psoriasis management are discussed.
Impact:
- Facilitates informed decision-making for healthcare providers managing psoriasis.
- Aims to improve patient outcomes and quality of life through effective topical treatment strategies.
- Contributes to the evidence base for dermatological treatment guidelines.
Related Concept Videos
Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.